Yahoo Web Search

Search results

1. • The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of...

     Morningstar· 6 days ago

     The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (“Biogen” or the “Company ...

2. • BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...

     WKBN 27 Youngstown· 6 days ago

     Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Biogen Inc." ...

3. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 4 days ago

     NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged

4. • 

     Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

     Zacks via Yahoo Finance· 5 days ago

     Biogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s stock...

5. • Small Business - Picayune Item | Picayune Item

     The Picayune Item· 2 days ago

     The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...

6. • 

     European Commission grants marketing approval to Biogen's ALS drug

     Reuters· 5 days ago

     , opens new tab said on Thursday that the European Commission has granted marketing authorization...

7. • Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors

     Guru Focus· 5 days ago

     Long-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth, and valuation ...

8. • Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...

     Morningstar· 6 days ago

     Biogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen ...

9. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 3 days ago

     Captioned Gray v. Biogen Inc., No. 24-cv-01444 (D. Colo.), the Biogen class action lawsuit charges Biogen as well as certain of Biogen’s top current and ...

10. • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 6 days ago

      BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! PR Newswire NEW YORK, May 30, 2024 NEW YORK, May 30, 2024 /PRNewswire/ -- Attorney